These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
148 related articles for article (PubMed ID: 20200782)
1. Amikacin in neonates: dosing recommendations should be based on both pharmacokinetics and dynamics. Allegaert K; Sherwin CM Singapore Med J; 2010 Jan; 51(1):88-9. PubMed ID: 20200782 [No Abstract] [Full Text] [Related]
2. Interindividual variability of aminoglycoside pharmacokinetics in preterm neonates at birth. Allegaert K; Anderson BJ Eur J Clin Pharmacol; 2006 Dec; 62(12):1011-2. PubMed ID: 17006675 [No Abstract] [Full Text] [Related]
3. Dopamine is not an independent risk factor for reduced amikacin clearance in extremely low-birth-weight infants. Allegaert K; Debeer A; Cossey V; Rayyan M; Devlieger H Pediatr Crit Care Med; 2006 Mar; 7(2):143-6. PubMed ID: 16446602 [TBL] [Abstract][Full Text] [Related]
4. Individualised dosing of amikacin in neonates: a pharmacokinetic/pharmacodynamic analysis. Sherwin CM; Svahn S; Van der Linden A; Broadbent RS; Medlicott NJ; Reith DM Eur J Clin Pharmacol; 2009 Jul; 65(7):705-13. PubMed ID: 19305985 [TBL] [Abstract][Full Text] [Related]
5. Renal drug clearance in preterm neonates: relation to prenatal growth. Allegaert K; Anderson BJ; van den Anker JN; Vanhaesebrouck S; de Zegher F Ther Drug Monit; 2007 Jun; 29(3):284-91. PubMed ID: 17529884 [TBL] [Abstract][Full Text] [Related]
6. Population pharmacokinetics and dosing of amoxicillin in (pre)term neonates. Pullen J; Stolk LM; Nieman FH; Degraeuwe PL; van Tiel FH; Zimmermann LJ Ther Drug Monit; 2006 Apr; 28(2):226-31. PubMed ID: 16628135 [TBL] [Abstract][Full Text] [Related]
7. Population pharmacokinetics and dosing of amoxicillin in (pre)term neonates. van den Anker JN Ther Drug Monit; 2006 Dec; 28(6):816; author reply 816-7. PubMed ID: 17164701 [No Abstract] [Full Text] [Related]
8. [Use of aminoglycoside antibiotic gentamycin in extremely premature infants--administration schedule and suggested dosage based on pharmacokinetic studies in plasma]. Slŭncheva B; Emilova Z; Vakrilova L; Pramatarova T; Popivanova A; Svinarov D Akush Ginekol (Sofiia); 2006; 45(3):30-3. PubMed ID: 16889185 [TBL] [Abstract][Full Text] [Related]
9. Population pharmacokinetics of gentamicin in premature newborns. García B; Barcia E; Pérez F; Molina IT J Antimicrob Chemother; 2006 Aug; 58(2):372-9. PubMed ID: 16782742 [TBL] [Abstract][Full Text] [Related]
10. A study of once-daily amikacin with low peak target concentrations in intensive care unit patients: pharmacokinetics and associated outcomes. Bacopoulou F; Markantonis SL; Pavlou E; Adamidou M J Crit Care; 2003 Jun; 18(2):107-13. PubMed ID: 12800120 [TBL] [Abstract][Full Text] [Related]
11. Increased amikacin dosage requirements in burn patients receiving a once-daily regimen. Conil JM; Georges B; Breden A; Segonds C; Lavit M; Seguin T; Coley N; Samii K; Chabanon G; Houin G; Saivin S Int J Antimicrob Agents; 2006 Sep; 28(3):226-30. PubMed ID: 16908121 [TBL] [Abstract][Full Text] [Related]
12. Prospective Evaluation of a Model-Based Dosing Regimen for Amikacin in Preterm and Term Neonates in Clinical Practice. Smits A; De Cock RF; Allegaert K; Vanhaesebrouck S; Danhof M; Knibbe CA Antimicrob Agents Chemother; 2015 Oct; 59(10):6344-51. PubMed ID: 26248375 [TBL] [Abstract][Full Text] [Related]
13. Limited predictability of amikacin clearance in extreme premature neonates at birth. Allegaert K; Anderson BJ; Cossey V; Holford NH Br J Clin Pharmacol; 2006 Jan; 61(1):39-48. PubMed ID: 16390350 [TBL] [Abstract][Full Text] [Related]
14. Population pharmacokinetics and dosing of flucloxacillin in preterm and term neonates. Pullen J; de Rozario L; Stolk LM; Degraeuwe PL; van Tiel FH; Zimmermann LJ Ther Drug Monit; 2006 Jun; 28(3):351-8. PubMed ID: 16778719 [TBL] [Abstract][Full Text] [Related]
15. Impact of ibuprofen administration on renal drug clearance in the first weeks of life. Allegaert K; Rayyan M; Anderson BJ Methods Find Exp Clin Pharmacol; 2006 Oct; 28(8):519-22. PubMed ID: 17136231 [TBL] [Abstract][Full Text] [Related]
16. Empirical models for dosage optimization of four beta-lactams in critically ill septic patients based on therapeutic drug monitoring of amikacin. Delattre IK; Musuamba FT; Verbeeck RK; Dugernier T; Spapen H; Laterre PF; Wittebole X; Cumps J; Taccone FS; Vincent JL; Jacobs F; Wallemacq PE Clin Biochem; 2010 Apr; 43(6):589-98. PubMed ID: 20036226 [TBL] [Abstract][Full Text] [Related]
17. Aminoglycoside pharmacokinetics in neonates: the need to search for covariates of variability in addition to case descriptions. Allegaert K Acta Paediatr; 2009 Oct; 98(10):1546; author reply 1546-7. PubMed ID: 19659582 [No Abstract] [Full Text] [Related]
18. [Urinary excretion of ampicillin in premature and small-for-gestational-age full-term neonates]. Gamboa R; Relier JP; Catz CS Ann Pediatr (Paris); 1976 Oct; 23(10):627-32. PubMed ID: 16106890 [No Abstract] [Full Text] [Related]
19. Amikacin Pharmacokinetics To Optimize Dosing in Neonates with Perinatal Asphyxia Treated with Hypothermia. Cristea S; Smits A; Kulo A; Knibbe CAJ; van Weissenbruch M; Krekels EHJ; Allegaert K Antimicrob Agents Chemother; 2017 Dec; 61(12):. PubMed ID: 28993332 [TBL] [Abstract][Full Text] [Related]
20. Amikacin dosing in neonates: evaluation of a dosing chart based on population pharmacokinetic data. Petersen PO; Wells TG; Kearns GL Dev Pharmacol Ther; 1991; 16(4):203-11. PubMed ID: 1782838 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]